ClinicalTrials.gg
CompletedNCT04998721MInDUpdated Nov 4, 2026Results posted

A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care

An interventional study of Promoting First Relationships-Brief and Perinatal Integrated Care in Depression, Postpartum, Efficacy, Self and Anxiety, sponsored by University of Washington. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by University of Washington · Not applicable, Interventional, and Treatment

How we know

Updated Nov 4, 2026Now CompletedResults posted+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 220 studies in Depression, Postpartum with a site in United States — 38 open to participants now, 49 under way, 3 of them phase 3. Depression, Postpartum · United States.

Enrollment
176th of 198
16 · median 86
Started
2022
with 11 others
No phase
152 of 220
32 open now
Registered
139th of 220
by date

Among the 220 studies in Depression, Postpartum with a site in United States, this one is the 176th largest by enrollment of the 198 interventional ones that give a count, is one of 12 that started in 2022, is one of 152 with no phase, and was the 139th registered.

Depression, Postpartum

570 studies on the registry are indexed under Depression, Postpartum; 135 are open to participants now.

Browse Depression, Postpartum studies →

Open to participants now

38 of the 220 studies in Depression, Postpartum with a site in United States are open now. Recruiting first, the newest first:

33 more — sign in →

All 38 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 88 Depression, Postpartum studies recruiting now, 54 (61%) set no upper age limit and 31 (35%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 220 studies in Depression, Postpartum with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to assess the effectiveness of a parenting intervention+usual care compared to usual care on postpartum depression and other mental health and parenting outcomes, as well as the feasibility and acceptability of the parenting intervention.

Read the detailed description

Eligible and consenting participants will be randomized in a single blind manner (research visitor will be blinded to condition) at a 1:1 ratio to either MInD (parenting intervention and usual integrated care) or usual integrated care in their second trimester of pregnancy. Research assessments will be administered during pregnancy and post-partum.

03

Conditions studied

  • Depression, Postpartum
  • Efficacy, Self
  • Anxiety
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • English speaking pregnant women between gestational age (GA) 13 - 24 weeks
  • ≥ 18 years,
  • EPDS score ≥10,
  • Ability to send and receive text messages (TM)

Exclusion criteria

Exclusion Criteria:

  • Severe substance use disorder in the past 6 months (score of 4 or above on the Alcohol Use Disorders Test AUDIT-C or a score of 6 or more on the Drug Abuse Screening Test (DAST).
  • Active suicidal ideation as measured by follow up to a positive answer to question 10 on the EPDS.
  • Bipolar disorder (Composite International Diagnostic Interview score ≥7) or psychotic disorder (assessed by chart review);
  • Multiple gestation (assessed by self-report and medical record);
  • Ongoing active treatment with psychotropic medications by mental health specialist (but not a PCP or Obstetrician).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Maternal Infant Dyadic Care

    Perinatal integrated care and Promoting First Relationships-Brief

    Behavioral: Promoting First Relationships-Brief · Behavioral: Perinatal Integrated Care

  • Active comparator
    Control

    Perinatal integrated care only

    Behavioral: Perinatal Integrated Care

Interventions

  • BehavioralPromoting First Relationships-Brief

    A brief version of the evidence based Promoting First Relationships (PFR) parenting intervention in which a parent is supported in appropriate interpretation of infant cues and in developing skills to effectively parent an infant. Sessions consist of reflective content (observing and reflecting back to the mother on patterns of dyadic interaction) and informational handouts. Reflective content will be delivered in person, and text messaging protocol will deliver informational content at developmentally appropriate times. PFR-B sessions are delivered in primary care settings beginning in the third trimester and continuing postpartum.

  • BehavioralPerinatal Integrated Care

    Integrated Care (IC) is an integrated care model that is effective in the treatment of perinatal depression. CC provides team driven, population focused, measurement guided and evidence based care to improve access and outcomes, control costs, and increase patient satisfaction.

06

What researchers measure

Primary outcomes

  1. Change From Baseline in Perinatal Depression on the PHQ-9

    The PHQ-9 is a nine -item self-report depression measure with higher scores indicating increased symptom severity, total score ranging from 0 to 27 and is validated for use in the perinatal period.

    Time frame: Baseline, 3 Months Postpartum, 6 Months Postpartum

Secondary outcomes

  1. Change From Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)

    The SENR contains 16 items rated on 7-point scales regarding mothers' perceptions of their competence on basic skills required in caring for an infant (e.g., "I feel confident in my role as a parent," "I can soothe my baby easily when he or she is crying or fussing") In the prenatal assessment questions address how women expect to do once their infant is born (e.g., "I look forward to becoming a parent with confidence in my role as a parent," "I expect to be able to soothe my baby easily when he or she is crying or fussing"). Scores on the SENR are obtained by summing individual items to yield a total efficacy score, with higher scores reflecting greater feelings of efficacy. Minimum score is 16 and maximum score is 112.

    Time frame: Baseline, 3 Months Postpartum, 6 Months Postpartum

  2. Change From Postpartum Baseline in Dyadic Interaction

    The Nursing Child Assessment Teaching Scale (NCAST) is an observational measure of the quality of caregiver-child dyadic interaction during a brief teaching activity, assessing caregiver sensitivity, responsiveness, and behaviors that foster the child's social-emotional and cognitive development. The caregiver subscale consists of four caregiver subscales comprising 50 items. Each item is scored dichotomously (0 = behavior not observed; 1 = behavior observed), giving a total caregiver score range of 0-50. Higher scores indicate more favorable caregiver-child interaction, reflecting greater caregiver sensitivity. NCATS is scored by observing a 3 minute videotaped session of mother and child interactive behavior.

    Time frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum

  3. Change From Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)

    WHODAS 2.0 is a 12 item assessment of overall functioning. The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed, total score ranging from 0 to 48. Higher scores indicate higher disability, that is higher values indicate a worse outcome.

    Time frame: Baseline, 3 Months Postpartum, 6 Months Postpartum

  4. Change From Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)

    The BIMF is a 20-item self-report measure for use in the first year postpartum and can assess overall functioning in the context of new motherhood. It measures the functional domains of social support, management, mother-child interaction, infant care, self-care, adjustment, and psychological well-being (of the mother). It is measured only postpartum. A total score is generated from summing the 20 items and ranges from 0 to 120. Higher scores indicate better maternal functioning, a better outcome.

    Time frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum

Other outcomes

  1. Change in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over Time

    The WAI-SR is a measure of therapeutic alliance. It contains 12 items using a 5 point likert scale. Score range is 12 to 60, with higher scores indicating better therapeutic alliance, a better outcome.

    Time frame: Prenatal to 6 months PP

07

Results

Posted Nov 4, 2026
Limitations and caveats
Small sample size precludes power to calculate efficacy

Participant flow

Only pregnant mothers were enrolled, their infants were not enrolled into the study as participants. The study is described as dyadic as it addresses parenting in addition to depression. Care managers were not randomized and no quantitative data was collected from them.

Participant flow — Overall Study
MilestoneIntervention GroupControl
Started88
Completed65
Not completed23

Outcome measures

PrimaryChange From Baseline in Perinatal Depression on the PHQ-9

The PHQ-9 is a nine -item self-report depression measure with higher scores indicating increased symptom severity, total score ranging from 0 to 27 and is validated for use in the perinatal period.

Time frame:
Baseline, 3 Months Postpartum, 6 Months Postpartum
Reported as:
Mean · scores on a scale
Change From Baseline in Perinatal Depression on the PHQ-9
scores on a scaleInterventionControl
Baseline13.88 ± 4.1212.38 ± 5.66
3 months PP8.33 ± 2.2510.83 ± 8.75
6 months PP6.33 ± 2.512 ± 6.4
SecondaryChange From Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)

The SENR contains 16 items rated on 7-point scales regarding mothers' perceptions of their competence on basic skills required in caring for an infant (e.g., "I feel confident in my role as a parent," "I can soothe my baby easily when he or she is crying or fussing") In the prenatal assessment questions address how women expect to do once their infant is born (e.g., "I look forward to becoming a parent with confidence in my role as a parent," "I expect to be able to soothe my baby easily when he or she is crying or fussing"). Scores on the SENR are obtained by summing individual items to yield a total efficacy score, with higher scores reflecting greater feelings of efficacy. Minimum score is 16 and maximum score is 112.

Time frame:
Baseline, 3 Months Postpartum, 6 Months Postpartum
Reported as:
Mean · scores on a scale
Change From Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)
scores on a scaleInterventionControl
Baseline90.25 ± 19.9687.33 ± 23.73
3 months PP93.67 ± 21.3791.17 ± 15.79
6 months PP100.17 ± 17.9990 ± 12.92
SecondaryChange From Postpartum Baseline in Dyadic Interaction

The Nursing Child Assessment Teaching Scale (NCAST) is an observational measure of the quality of caregiver-child dyadic interaction during a brief teaching activity, assessing caregiver sensitivity, responsiveness, and behaviors that foster the child's social-emotional and cognitive development. The caregiver subscale consists of four caregiver subscales comprising 50 items. Each item is scored dichotomously (0 = behavior not observed; 1 = behavior observed), giving a total caregiver score range of 0-50. Higher scores indicate more favorable caregiver-child interaction, reflecting greater caregiver sensitivity. NCATS is scored by observing a 3 minute videotaped session of mother and child interactive behavior.

Time frame:
6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
Reported as:
Mean · scores on a scale
Change From Postpartum Baseline in Dyadic Interaction
scores on a scaleInterventionControl
6 weeks PP37.67 ± 5.6837 ± 4.95
3 months PP40.33 ± 3.5638.5 ± 9.09
6 months PP35.60 ± 5.3733.60 ± 8.17
SecondaryChange From Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)

WHODAS 2.0 is a 12 item assessment of overall functioning. The scores assigned to each of the items - "none" (0), "mild" (1) "moderate" (2), "severe" (3) and "extreme" (4) - are summed, total score ranging from 0 to 48. Higher scores indicate higher disability, that is higher values indicate a worse outcome.

Time frame:
Baseline, 3 Months Postpartum, 6 Months Postpartum
Reported as:
Mean · scores on a scale
Change From Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)
scores on a scaleInterventionControl
Baseline41.67 ± 13.5537.24 ± 13.24
3 months PP21.18 ± 16.6424.65 ± 9.07
6 months PP11.81 ± 11.0821.67 ± 9.39
SecondaryChange From Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)

The BIMF is a 20-item self-report measure for use in the first year postpartum and can assess overall functioning in the context of new motherhood. It measures the functional domains of social support, management, mother-child interaction, infant care, self-care, adjustment, and psychological well-being (of the mother). It is measured only postpartum. A total score is generated from summing the 20 items and ranges from 0 to 120. Higher scores indicate better maternal functioning, a better outcome.

Time frame:
6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
Reported as:
Mean · scores on a scale
Change From Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)
scores on a scaleInterventionControl
6 weeks PP91.29 ± 14.9293.17 ± 17.95
3 months PP96.4 ± 12.2288.17 ± 22.66
6 months PP99.67 ± 11.2789.2 ± 18.82
Other pre-specifiedChange in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over Time

The WAI-SR is a measure of therapeutic alliance. It contains 12 items using a 5 point likert scale. Score range is 12 to 60, with higher scores indicating better therapeutic alliance, a better outcome.

Time frame:
Prenatal to 6 months PP
Reported as:
Mean · scores on a scale
Change in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over Time
scores on a scaleInterventionControl
Prenatal48.94 ± 11.2749.38 ± 7.29
6 months PP52.50 ± 10.0553.73 ± 5.64

Adverse events

Collected over From baseline up to final assessment at 6 months PP. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/8 (0%)0/8 (0%)2/8 (25%)
Control0/8 (0%)0/8 (0%)4/8 (50%)
Most frequent other events
Most frequent other events
EventInterventionControl
Suicidal ideationPsychiatric disorders2/84/8

Baseline characteristics

Age, Continuous
Age, Continuous(years)InterventionControlTotal
Mean32.19 ± 7.4230.11 ± 5.231.15 ± 6.28
Sex: Female, Male
Sex: Female, Male(Participants)InterventionControlTotal
Female8816
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)InterventionControlTotal
American Indian or Alaska Native000
Asian314
Native Hawaiian or Other Pacific Islander000
Black or African American000
White369
More than one race112
Unknown or Not Reported101
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)InterventionControlTotal
Hispanic or Latino011
Not Hispanic or Latino7714
Unknown or Not Reported101
Patient Health Questionnaire - 9
Patient Health Questionnaire - 9(scores on a scale)InterventionControlTotal
Mean13.88 ± 4.1212.38 ± 5.6613.13 ± 4.84
08

Study locations

1 site
  • Amritha Bhat
    Seattle, Washington 98195, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2022 to primary completion in Apr 2025, 29 months.

Results were first posted in Nov 2026, 1 year 6 months after primary completion.

Of 259 non-industry interventional studies with no phase under Depression, Postpartum, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 35. This study's 29 months is above that.

Counting every sponsor, half of 265 studies reached it within 23 months; a quarter within 11 and three quarters within 35.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: primary completion Mar 2025 → Apr 2025 and completion Jun 2025 → Apr 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 22, 2021
First posted
Aug 10, 2021
StartActual
Nov 1, 2022
Primary completionActual
Apr 7, 2025was Mar 2025
CompletionActual
Apr 7, 2025was Jun 2025
Results first posted
Nov 4, 2026
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 4, 2026
Results
Results posted
posted Nov 4, 2026
Primary completion
Mar 1, 2025→Apr 7, 2025 (actual)
Nov 4, 2026
Study completion
Jun 1, 2025→Apr 7, 2025 (actual)
Nov 4, 2026
Enrollment
60 (estimated)→16 (actual)
Nov 4, 2026
Interventions
Changed Perinatal Collaborative Care→Perinatal Integrated Care
Nov 4, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChange fromFrom Baseline in Perinatal Depression Symptomology on the Edinburgh Postnatal Depression Scale (EPDS)PHQ-9Time frame: Baseline, 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum → Baseline, 3 Months Postpartum, 6 Months Postpartum
Nov 4, 2026
Documents
Secondary outcomes
4 edited, 1 added, 2 removed
What changed in the outcomes
  • EditedChange fromFrom Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)Time frame: Baseline, 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum → Baseline, 3 Months Postpartum, 6 Months Postpartum
  • EditedChange fromFrom Postpartum Baseline in Dyadic InteractionTime frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
  • EditedChange fromFrom Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)Time frame: Baseline, 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum → Baseline, 3 Months Postpartum, 6 Months Postpartum
  • EditedChange fromFrom Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)Time frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
  • RemovedRelative utilization of MInD vs usual CCTime frame: Baseline through up to 6 Months Postpartum (up to maximum of 9 months)
  • RemovedPerceived match of treatment to patient need using Working Alliance Inventory (WAI-SR)Time frame: 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
  • Addedother outcomeChange in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over TimeTime frame: Prenatal to 6 months PP
Nov 4, 2026
Design
Phase 2→Not applicable
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Recruiting→Completed
    Results posted
    Primary completion Mar 1, 2025→Apr 7, 2025 (now actual)
    Study completion Jun 1, 2025→Apr 7, 2025 (now actual)
    Enrollment 60 (estimated)→16 (actual)
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChange fromFrom Baseline in Perinatal Depression Symptomology on the Edinburgh Postnatal Depression Scale (EPDS)PHQ-9Time frame: Baseline, 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum → Baseline, 3 Months Postpartum, 6 Months Postpartum
    Secondary outcomes 4 edited, 1 added, 2 removed
    What changed in the outcomes
    • EditedChange fromFrom Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)Time frame: Baseline, 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum → Baseline, 3 Months Postpartum, 6 Months Postpartum
    • EditedChange fromFrom Postpartum Baseline in Dyadic InteractionTime frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
    • EditedChange fromFrom Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)Time frame: Baseline, 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum → Baseline, 3 Months Postpartum, 6 Months Postpartum
    • EditedChange fromFrom Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)Time frame: 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
    • RemovedRelative utilization of MInD vs usual CCTime frame: Baseline through up to 6 Months Postpartum (up to maximum of 9 months)
    • RemovedPerceived match of treatment to patient need using Working Alliance Inventory (WAI-SR)Time frame: 30-34 Weeks Gestational Age, 6 Weeks Postpartum, 3 Months Postpartum, 6 Months Postpartum
    • Addedother outcomeChange in Working Alliance Inventory - Short Revised (WAI-SR) Scores Over TimeTime frame: Prenatal to 6 months PP
    Interventions Changed Perinatal Collaborative Care→Perinatal Integrated Care
    Design Phase 2→Not applicable
    + 5 other changes: verification date, description, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04998721
Responsible party
Amritha Subray Bhat (Assistant Professor, School of Medicine: Psychiatry, University of Washington) — Principal investigator
First posted
Aug 10, 2021
Start date
Nov 1, 2022
Primary completion
Apr 7, 2025
Completion
Apr 7, 2025
Results posted
Nov 4, 2026
Last update
Nov 4, 2026

Study contacts

Amritha S Bhat, MD, MPH
principal investigator · University of Washington

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion